Heidelberg Pharma AG and Huadong Medicine Co Ltd to Announce Strategic Partnership with Equity Participation Call Transcript

Feb 28, 2022 / 12:00PM GMT
Jan Schmidt-Brand - Heidelberg Pharma AG - CEO & CFO

Hello, and [Ni hao] ladies and gentlemen. It's my great pleasure to welcome you to the Heidelberg Pharma conference call to discuss the transformative strategic partnership with Huadong that we announced over the weekend. My name is Jan Schmidt-Brand, and I'm CEO and CFO of the company.

Please note that this presentation is available for download on the Heidelberg Pharma website. This conference call is being recorded, and the replay will be available on our website after the live event.

Before I begin, let me remind you that we will be making forward-looking statements on this call as well as during the question-and-answer session. Please see our safe harbor statement on Slide 2. For a more detailed discussion of the risks and uncertainties affecting our business, please see the 2020 management report, which is available on our website.

Therefore, I would like -- sorry, joining me on the call today are my colleagues Dr. George Badescu, Chief Business Officer; and Professor Andreas Pahl, Chief Scientific

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot